News

Orient EuroPharma (OEP) acquires a stake in Quantum Genomics

Quantum Genomics launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension

Delpharm Group selected for large-scale production of firibastat tablets

Quantum Genomics to give an exclusive license for firibastat in Greece

Boursorama – Le Journal des Biotechs: Interview with Jean-Philippe Milon (in French)

Very successfull private placement

Quantum Genomics to give an exclusive license for firibastat in South Korea

Launch of a capital increase by private placement

LaTribune.fr – La Matinale de l’Entrepreneur: Interview with Jean-Philippe Milon (in French)

Figaro.fr/Espace Économie – Entreprise & Innovation: Interview with Jean-Philippe Milon (in French)